Abstract: Provided herein are pharmaceutical compositions comprising one or more phosphodiesterase inhibitors of type IV (""PDE-IV"), and atleast one other active ingredients selected from muscarinic receptor antagonists (MR/\), [32-agonists. p38 MAP Kinase inhibitors, and corticosteroids and especially one or more pharmaceutically acceptable excipients and/or other therapeutic agents. In addition methods of treating autoimmune, inflammatory or allergic diseases or disorders are provided.
| # | Name | Date |
|---|---|---|
| 1 | 4536-delnp-2008-abstract.pdf | 2011-08-21 |
| 1 | 4536-delnp-2008-form-2.pdf | 2011-08-21 |
| 2 | 4536-delnp-2008-claims.pdf | 2011-08-21 |
| 2 | 4536-delnp-2008-form-1.pdf | 2011-08-21 |
| 3 | 4536-delnp-2008-correspondence-others.pdf | 2011-08-21 |
| 3 | 4536-delnp-2008-description (complete).pdf | 2011-08-21 |
| 4 | 4536-delnp-2008-correspondence-others.pdf | 2011-08-21 |
| 4 | 4536-delnp-2008-description (complete).pdf | 2011-08-21 |
| 5 | 4536-delnp-2008-claims.pdf | 2011-08-21 |
| 5 | 4536-delnp-2008-form-1.pdf | 2011-08-21 |
| 6 | 4536-delnp-2008-abstract.pdf | 2011-08-21 |
| 6 | 4536-delnp-2008-form-2.pdf | 2011-08-21 |